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Deliver or wait with late preterm 
membrane rupture?
While ACOG recommends delivery for all women with 
ruptured membranes after 34 weeks’ gestation, a new 
study finds expectant management may be the way to go. 
PRACTICE CHANGER
In the absence of clinical indications for 
delivery, consider expectant management 
in women with premature rupture of mem-
branes in late preterm stages (34 weeks to 
36 weeks, 6 days). 
STRENGTH OF RECOMMENDATION
B: Based on one well-designed randomized 
controlled trial.1
Morris JM, Roberts CL, Bowen JR, et al; PPROMT Collaboration. Im-
mediate delivery compared with expectant management after preterm 
pre-labour rupture of the membranes close to term (PPROMT trial): a 
randomised controlled trial. Lancet. 2016;387:444-452.
ILLUSTRATIVE CASE
A 26-year-old G2P1001 at 35 weeks, 2 days of 
gestation presents with leakage of clear fluid 
for the last 2 hours. There is obvious pooling in 
the vaginal vault, and rupture of membranes 
is confirmed with appropriate testing. Her 
cervix is closed, she is not in labor, and tests 
of fetal well-being are reassuring. She had an 
uncomplicated vaginal delivery with her first 
child. How should you manage this situation? 
Preterm premature rupture of mem-branes (PPROM)—when rupture of membranes occurs before 37 weeks’ 
gestation—affects about 3% of all pregnancies 
in the United States, and is a major contribu-
tor to perinatal morbidity and mortality.2,3 
PPROM management remains controversial, 
especially during the late preterm stage 
(ie, 34 weeks to 36 weeks, 6 days). Non-
reassuring fetal status, clinical chorioam-
nionitis, cord prolapse, and significant 
placental abruption are clear indications 
for delivery. In the absence of those factors, 
delivery vs expectant management is deter-
mined by gestational age. Between 23 and 
34 weeks’ gestation, when the fetus is at or 
close to viability, expectant management is 
recommended, provided there are no signs 
of infection or maternal or fetal compromise.4 
This is because of the significant morbidity 
and mortality associated with births before 
34 weeks’ gestation.4 
The American College of Obstetricians 
and Gynecologists (ACOG) currently recom-
mends delivery for all women with rupture of 
membranes after 34 weeks’ gestation, while 
acknowledging that this recommendation is 
based on “limited and inconsistent scientific 
evidence.”5 The recommendation for delivery 
after 34 weeks is predicated on the belief that 
disability-free survival is high in late preterm 
infants. However, there is a growing body 
of evidence that shows negative short- and 
long-term effects for these children, includ-
ing medical concerns, academic difficulties, 
and more frequent hospital admissions in 
early childhood.6,7
STUDY SUMMARY
Higher birth weights, fewer C-sections, 
and no increased sepsis with wait-and-see
The Preterm Pre-labour Rupture Of the Mem-
branes close to Term (PPROMT) trial was a 
821JFPONLINE.COM VOL 65, NO 11  |  NOVEMBER 2016  |  THE JOURNAL OF FAMILY PRACTICE
multicenter (65 institutions across 11 coun-
tries), randomized controlled trial (RCT) 
that included 1839 women with singleton 
pregnancies and confirmed rupture of mem-
branes between 34 weeks and 36 weeks, 
6 days’ gestation.1 Conducted from May 2004 
to June 2013, participants were randomized to 
expectant management (915 women) vs im-
mediate delivery by induction (924 women). 
Patients and care providers were not 
masked to treatment allocation, but those 
determining the primary outcome were 
masked to group allocation. 
One woman in each group was lost to 
follow-up, and 2 additional women withdrew 
from the immediate birth group. Women 
already in active labor or with clinical 
indications for delivery (chorioamnionitis, 
abruption, cord prolapse, fetal distress) were 
excluded. The baseline characteristics of the 
2 groups were similar. 
Women in the induction group had 
delivery scheduled as soon as possible 
after randomization. Women in the expectant 
management group were allowed to go into 
spontaneous labor and were only induced if 
they reached term or the clinician identified 
other indications for immediate delivery. 
The primary outcome was probable or 
confirmed neonatal sepsis. Secondary infant 
 outcomes included a composite neonatal 
morbidity and mortality indicator (sepsis, me-
chanical ventilation ≥24 hours, still birth, or 
neonatal death), respiratory distress syndrome, 
any mechanical ventilation, birth weight, and 
duration of stay in a neonatal intensive care 
unit (NICU) or special care nursery. Second-
ary maternal outcomes included antepartum 
or intrapartum hemorrhage, intrapartum 
fever, mode of delivery, duration of hospital 
stay, and development of chorioamnionitis in 
the expectant management group.
The primary outcome of neonatal sep-
sis occurred in 2% of the neonates assigned 
to immediate delivery and 3% of neonates 
assigned to expectant management (rela-
tive risk [RR]=0.8; 95% confidence interval 
[CI], 0.5-1.3; P=.37). There was also no sta-
tistically significant difference in composite 
neonatal morbidity and mortality (RR=1.2; 
95% CI, 0.9-1.6; P=.32). However, infants 
born in the immediate delivery group had 
significantly lower birth weights (2574.7 g 
vs 2673.2 g; absolute difference= -125 g; 
P<.0001), a higher incidence of respiratory 
distress (RR=1.6; 95% CI, 1.1-2.3; P=.008; 
number needed to treat [NNT]=32), and 
spent more time in the NICU/special care 
nursery (4 days vs 2 days; P<.0001).
Compared to immediate delivery, 
expectant management was associated with 
a higher likelihood of antepartum or intra-
partum hemorrhage (RR=0.6; 95% CI, 0.4-0.9; 
P=.02; number needed to harm [NNH]=50) 
and intrapartum fever (RR=0.4; 95% CI, 
0.2-0.9; P=.02; NNH=100). In the women 
assigned to immediate delivery, 26% had a 
cesarean section, compared to 19% in the 
expectant management group (RR=1.4; 95% 
CI, 1.2-1.7, P=.0001; NNT=14). A total of 
56 women (6%) assigned to the expectant 
management group developed clinically sig-
nificant chorioamnionitis requiring delivery. 
All other secondary maternal and neonatal 
outcomes were equivalent with no significant 
differences between the 2 groups. 
WHAT’S NEW?
Largest study to show no increased  
sepsis with expectant management
Two prior RCTs (the PPROMEXIL trial8 
and PPROMEXIL-29), involving a total of 
736 women, evaluated expectant manage-
ment vs induction in the late preterm stage 
of pregnancy. There was no increased risk of 
neonatal sepsis with expectant management 
in either study. However, those studies did not 
have sufficient power to show a statistically 
significant change in any of the outcomes. 
The PPROMT study is the largest one to 
show that immediate birth increases the risk 
of respiratory distress and duration of NICU/
special care stay for the baby and increases the 
risk of cesarean section for the mother. It also 
showed that the risk of neonatal sepsis was not 
higher in the expectant management group.  
CAVEATS
Findings only apply  
to singleton pregnancies
Delivery of the infants in the expectant man-
agement group was not by specified protocol; 
This study  
is the largest 
to show that 
immediate birth 
increases the risk 
of respiratory 
distress and  
duration  
of NICU stay.  
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each birth was managed according to the 
policies of the local center and clinician judg-
ment. Because of this, there was variation 
in fetal and maternal monitoring. The vast 
majority of women in both groups (92% 
to 93%) received intrapartum antibiotics. 
Expectant management should include care-
ful monitoring for infection and hemorrhage 
and may need to be changed to immediate 
delivery if one of these occurs.
The study participants all had singleton 
pregnancies; this recommendation cannot 
be extended to non-singleton pregnancies. 
However, a prior cesarean section was not an 
exclusion criterion for the study, and these 
recommendations would be valid for that 
group of women, too. 
CHALLENGES TO IMPLEMENTATION
Going against the tide of ACOG
The most recent ACOG guidelines, updated 
October 2016, recommend induction of labor 
for women with ruptured membranes in the 
late preterm stages.5 This may present a chal-
lenge to widespread acceptance of expectant 
management for PPROM.                 JFP 
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